Back to search
Stem Cell Transplant Complications
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Stem Cell Transplant Complications trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Stem Cell Transplant Complications trials you may qualify forThe aim of this study to evaluate the safety and efficacy of a nonmyeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSC…
This is a prospective, multicentre, phase III, randomised, controlled intervention study. Two groups of patients with equal numbers will be studied and each pa…
This single-center, non interventional cohort study investigates whether chronic iron overload influences the incidence of liver complications in adults who are…
The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity o…
The purpose of this study is to determine the efficacy and safety of combined Ruxolitinib With Corticosteroids as First Line Therapy for the severe acute GVHD (…
This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psych…
The transplantation of allogeneic haematopoietic stem cells (HSCs) can lead to serious complications after transplantation, such as graft-versus-host disease (G…
Revumenib is a first in class oral menin inhibitor that targets a central oncogenic dependency shared across KMT2Ar, NPM1m, and NUP98r AML. In addition to suppr…
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.